Trending News

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
Posted On Thursday, July 10, 2025
Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy
Posted On Thursday, July 10, 2025
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Posted On Thursday, July 10, 2025
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
Posted On Thursday, July 10, 2025
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
Posted On Thursday, July 10, 2025
AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth
Posted On Thursday, July 10, 2025
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL
Posted On Thursday, July 10, 2025
BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET
Posted On Thursday, July 10, 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment
Posted On Thursday, July 10, 2025
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
Posted On Thursday, July 10, 2025
Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum
Posted On Thursday, July 10, 2025
Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™
Posted On Thursday, July 10, 2025
PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results
Posted On Thursday, July 10, 2025
Cocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus Conference
Posted On Thursday, July 10, 2025
Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025
Posted On Thursday, July 10, 2025
Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
Posted On Thursday, July 10, 2025
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference
Posted On Thursday, July 10, 2025
Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease
Posted On Thursday, July 10, 2025
Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
Posted On Thursday, July 10, 2025
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
Posted On Thursday, July 10, 2025
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
Posted On Thursday, July 10, 2025
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock
Posted On Thursday, July 10, 2025
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025
Posted On Thursday, July 10, 2025
Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
Posted On Thursday, July 10, 2025
DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project
Posted On Thursday, July 10, 2025

Print